share_log

BTIG Upgrades Globus Medical to Buy, Announces $60 Price Target

Moomoo 24/7 ·  Mar 18 08:06

BTIG analyst Ryan Zimmerman upgrades Globus Medical (NYSE:GMED) from Neutral to Buy and announces $60 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment